Navigation Links
Artificial induction of immunity


Immunity against infections that can cause serious illness is generally beneficial. Since Pasteur provided support for a germ theory of infectious disease, we have increasingly induced immunity against a widening range of diseases to prevent the associated risks from the wild infections. It is hoped that further understanding of the molecular basis of immunity will translate to improved clinical practice in the future.

This article places the development of techniques in historical and logical sequence and points to detailed articles on each of the main topics.

Contents


Variolation and smallpox

See main articles variolation and smallpox.

Typical site of inoculation in Europe and the British colonies

The earliest recorded artificial induction of immunity in humans was by variolation or inoculation, which is the controlled infection of a less lethal natural form of smallpox (known as Variola Minor) into a subject to make him or her immune to re-infection with the more lethal natural form, Variola Major. This was practiced in ancient times in China and India, and imported into Europe, via Turkey, around 1720 by Lady Montagu and perhaps others. From England, the technique spread rapidly to the Colonies, and was also spread by African slaves arriving into Boston.[1] [2]

Variolation had the disadvantage that the inoculating agent used, Variola Minor, was still an active form of smallpox and, although less potent, could still kill the inoculee or spread in its full form to others nearby. However, as the risk of death from inoculation with Variola Minor was just 1% to 2%, as compared to the 20% risk of death from the natural form of smallpox, the risks of inoculation were generally considered acceptable.

Vaccination

See main articles vaccination and Edward Jenner.

In 1796, Edward Jenner, a doctor and scientist who had practiced variolation, performed an experiment based on the folk-knowledge that infection with cowpox, a disease with minor symptoms which was never fatal, also conferred immunity to smallpox. [3] Jenner induced cowpox infection by transferring material from a lesion on one patient to another, thus infecting the second patient with cowpox. He then demonstrated that the latter was immune by exposing him to smallpox. The principle had been demonstrated some years earlier by Benjamin Jesty, who had not publicized his discovery. Jenner described and generalised the process and then arranged to propagate cowpox for therapeutic use and he is credited with the discovery.[4] Vaccination took over from variolation.

Jenner, like all members of the Royal Society in those days, was an empiricist. The theory to support further advances in vaccination came later.

Germ theory

See main articles Pasteur and germ theory.

Pasteur perfected experiments which disproved the then-popular theory of spontaneous generation and from which he derived the modern germ theory of (infectious) disease. Using experiments based on this theory, which posited that specific microorganisms cause specific diseases, Pasteur isolated the infectious agent from anthrax. He then derived a vaccine by altering the infectious agent so as to make it harmless and then introducing this inactivated form of the infectious agents into farm animals, which then proved to be immune to the disease.

Pasteur also isolated a crude preparation of the infectious agent for rabies. In a brave piece of rapid medicine development, he probably saved the life of a person who had been bitten by a clearly rabid dog by performing the same inactivating process upon his rabies preparation and then inoculating the patient with it. The patient, who was expected to die, lived, and thus was the first person successfully vaccinated against rabies.

Anthrax is now known to be caused by a bacterium, and rabies is known to be caused by a virus. The microscopes of the time could reasonably be expected to show bacteria, but imaging of viruses had to wait until the development of electron microscopes with their greater resolving power in the 20th century.

Toxoids

Some diseases, such as tetanus, cause disease not by bacterial growth but by bacterial production of a toxin. Tetanus toxin is so lethal that humans cannot develop immunity to a natural infection, as the amount of toxin required to kill a person is much less than is required by the immune system to recognize the toxin and produce antibodies against it. However, heating the tetanus toxin enough to denature it causes it to lose its ability to produce disease, but still leaves it able to induce immunity to tetanus when injected into subjects. The heated, denatured toxin is called a toxoid.

See also Botulism

Adjuvants

The use of simple molecules such as toxoids for immunization tends to produce a low response by the immune system, and thus poor immune memory. However, adding certain substances to the mixture, for example adsorbing tetanus toxoid onto alum, greatly enhances the immune response. These substances are known as adjuvants. Several different adjuvants have been used in vaccine preparation. Adjuvants are also used in other ways in researching the immune system.

A more contemporary approach for "boosting" the immune response of simpler immunogenic molecules (known as antigens) is to conjugate the antigens. Conjugation is the attachment to the antigen of another substance which also generates an immune response, thus amplifying the overall response and causing a more robust immune memory to the antigen. For example, a toxoid might be attached to a polysaccharide from the capsule of the bacteria responsible for most lobar pneumonia.

Temporarily-induced immunity

See also immunoglobulin.

Image:Http://upload.wikimedia.org/wikipedia/commons/f/f2/Platypus.jpg
Platypus: monotremes lack placental transfer of immunity

Temporary immunity to a specific infection can be induced in a subject by providing the subject with externally produced immune molecules, known as antibodies or immunoglobulins. This was first performed (and is still sometimes performed) by taking blood from a subject who is already immune, isolating the fraction of the blood which contains antibodies (known as the serum), and injecting this serum into the person for whom immunity is desired. This is known as passive immunity, and the serum that is isolated from one subject and injected into another is sometimes called antiserum. Antiserum from other mammals, notably horses, has been used in humans with generally good and often life-saving results, but there is some risk of anaphylactic shock and even death from this procedure because the human body sometimes recognizes antibodies from other animals as foreign.

Passive immunity is temporary, because the antibodies which are transferred have a lifespan of only about 3-6 months. Every placental mammal (including humans) has experienced temporarily-induced immunity by transfer of homologous antibodies from its mother across the placenta, giving it passive immunity to whatever its mother was immune to. This allows some protection for the young while its own immune system is developing.

Synthetic (recombinant or cell-clone) human immunoglobulins can now be made, and for several reasons (including the risk of prion contamination of biological materials) are likely to be used more and more often. However, they are expensive to produce and are not in large-scale production as of 2006. In the future it might be possible to artificially design antibodies to fit specific antigens, then produce them in large quantities to induce temporary immunity in people in advance of exposure to a specific pathogen, such as a bacterium, a virus, or a prion. At present, the science to understand this process is available but not the technology to perform it.

References

Further references given in the main articles indicated above.

  1. ^ National Institutes of Health "Smallpox - A Great and Terrible Scourge" Variolation
  2. ^ Andrew Dickson White "A History of the Warfare of Science with Theology - Chapter 10: Theological Opposition to Inoculation, Vaccination and the use of Anaesthetics" New York D. Appleton and Company 1898 Full text
  3. ^ Harris F "Edward Jenner and Vaccination" World Wide School Full text
  4. ^ François Marie Arouet de Voltaire (1694–1778). Lettres Philosophiques "Letter XI—On Inoculation" The Harvard Classics. 1909–14. English translation
  • Essential Immunology. Roitt, I Blackwell Scientific Publications 3rt edition, subsequent revisions. ISBN 0-632-00276-X
  • Pier GB, Lyczak JB, and Wetzler LM. (2004). Immunology, Infection, and Immunity. ASM Press. ISBN 1-55581-246-5
  • Therapeutic antibodies Ganfyd on-line collaborative medical textbook.

'"/>


(Date:7/22/2014)... July 22, 2014 The Restful Jaw ... the Restful Jaw ®. The FDA-registered external device ... while minimizing jaw pain, fatigue and soreness during dental ... treatment times when patients do not need to take ... The Restful Jaw is a vital solution in helping ...
(Date:7/22/2014)... University of the Pacific's Arthur A. ... of its state-of-the-art, $151 million campus this month. The ... San Francisco's South of Market (SoMa) district and houses ... patients will now be greeted by a wall of ... , Advanced Kiosks engineering team designed custom software to ...
(Date:7/22/2014)... HealthDay Reporter , MONDAY, July 21, 2014 (HealthDay ... high school may take fewer health risks than their peers ... of low-income Los Angeles teens, found that those who attended ... binge-drink, have multiple sex partners or take certain other health ... kids" being more likely to go to good schools, researchers ...
(Date:7/22/2014)... 21, 2014) Investigators at the Cedars-Sinai Samuel ... multistep investigational treatment for one of the most ... advanced pancreatic cancer. , Locally advanced pancreatic ... solid tumor, with a cumulative five-year survival rate ... disease. Surgery is rarely an option for patients ...
(Date:7/22/2014)... like electroconvulsive therapy (ECT) and transcranial magnetic stimulation ... depression. Like antidepressant medications, however, they typically have ... receive several weeks of regular ECT treatments before ... is an impetus to develop antidepressant treatments that ... stimulation (LFMS) is one such potential new treatment ...
Breaking Medicine News(10 mins):Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 2Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 3Health News:iKiosks Are Gateway to Premier Dental Facility 2Health News:iKiosks Are Gateway to Premier Dental Facility 3Health News:Good Schools May Be Good for a Teen's Health, Too 2Health News:Good Schools May Be Good for a Teen's Health, Too 3Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 2Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 3Health News:Low strength brain stimulation may be effective for depression 2
... who take a multivitamin pill may think they can smoke ... of cigarettes, according to a new study. Researchers found ... reduce their risk of cancer, allowing them to light up ... virtuous behavior for a subsequent indulgence, known as the "licensing ...
... 4 (HealthDay News) -- People living in a region of ... known to have significantly higher rates of stroke deaths than ... are also at greater risk for sepsis, a severe illness ... examined death rates from sepsis across the United States," said ...
... Duke University Medical Center and Johns Hopkins University could ... therapy to treat the second most common type of ... for the primary cancer genes involved in the development ... the probable mutations, but not the particular gene information. ...
... , THURSDAY, Aug. 4 (HealthDay News) -- A ... common form of brain cancer appears to reveal the biological ... map by sequencing protein-coding genes in seven samples of tissue ... genes (CIC and FUBP1) not previously associated with those types ...
... Spanish . , Kidney transplant from a living donor, ... those affected by particular conditions, results in increased organ survival ... the mid-90 despite the high rate of cadaveric donation. According ... living donor kidney transplants were made, which represents 11% of ...
... U.S. meat processor Cargill announced late Wednesday that it was ... about 36 million pounds of ground turkey linked to an ... closer to the source of the outbreak, which the U.S. ... Californian and sickened at least 76 others across 26 states ...
Cached Medicine News:Health News:Smokers Mistakenly Believe Vitamins Protect Them From Cancer 2Health News:U.S. 'Stroke Belt' May Also Be 'Sepsis Belt' 2Health News:Elusive gene mutations found for malignant brain tumor 2Health News:Scientists May Have Found Missing Link to Common Brain Cancer 2Health News:Minimal scar techniques in living donors for kidney transplant 2Health News:Minimal scar techniques in living donors for kidney transplant 3Health News:Minimal scar techniques in living donors for kidney transplant 4Health News:Minimal scar techniques in living donors for kidney transplant 5Health News:Cargill Begins Massive Recall of Turkey Linked to Salmonella Outbreak 2Health News:Cargill Begins Massive Recall of Turkey Linked to Salmonella Outbreak 3
Other medicine definitionOther Tags